Lipid nanoparticles are novel drug delivery systems that enhance treatment outcomes in various ways, including targeting specificity, improving therapeutic efficacy, increasing water solubility, and reducing toxicity.
Over the past few years, the therapeutic landscape has evolved, and the pharmaceutical industry has developed a broad spectrum of therapeutics ranging from small molecules to next-generation biologics such as monoclonal antibodies, peptides, proteins, and cell therapies. These lipid nanoparticles emerge as advanced drug-delivery molecules that meet the target delivery requirement.
Given the growing requirement of drug delivery systems, the global lipid nanoparticle manufacturing market is anticipated to grow from USD 0.66 billion in 2023 to USD 2.53 billion by 2035. Further, the market was projected to increase at a CAGR of 11.8% from 2023-2035, according to Roots Analysis.
Lipid nanoparticles are highly versatile; they can be utilized as drug carriers to deliver a wide range of therapeutics and genetic material inside the cells. Several lipid nanoparticle manufacturing companies continuously undertake various initiatives which emphasize next-generation of lipid nanoparticles. These next-generation lipid nanoparticles include solid lipid nanoparticles, chitosan-coated polymers, and cationic lipids. The advanced drug delivery system can potentially protect drugs from the body’s environment and enhance biocompatibility.
Who Manufactures Lipid Nanoparticles (LNPs)?
Presently, the lipid nanoparticles manufacturing market landscape features more than 30 manufacturing organizations across the globe. These companies claim to have the required capabilities, infrastructure, and technology to provide a wide range of services for developing and manufacturing different lipid and metal nanoparticles. Interestingly, 93% of lipid nanoparticle technologies developed by the players engaged in this market support the delivery of drug formulation through injectable routes. The rising interest in lipid nanoparticles and the growing demand for target-specific delivery systems have increased partnership activities.
According to the Roots Analysis report, the top companies engaged in the development of lipid nanoparticle technology include Acuitas Therapeutics, Ascendia Pharmaceuticals, Integrated Nanotherapeutics, Leon-nano Drugs, Matinas BioPharma, Panthera Therapeutics, and TLC Biosciences.
Top 4 Trends in the Lipid Nanoparticles Manufacturing Market
1. Advances in Nanoparticles Characterization Techniques
Advancements in lipid nanoparticle characterization techniques play an essential role in precisely analyzing their properties and quality control for diverse applications. Cutting-edge technologies have enhanced conventional approaches, such as electron microscopy and dynamic light scattering. High-resolution imaging techniques such as scanning electron and transmission electron microscopy allow researchers to examine nanoparticles at the atomic level, enabling valuable insight into the size, shape, and surface morphology.
In addition, emerging technologies such as atomic force microscopy and nanoparticle tracking analysis provide a unique perspective on lipid nanoparticle interaction behavior. Technological advances contribute towards the fundamental understanding of nanoparticle characteristics and facilitate the fine-tuning of lipid nanoparticle properties to meet specific requirements in applications ranging from drug delivery to healthcare.
2. Lipid Nanoparticles Application Diversity
Currently, manufacturers of metal and lipid nanoparticles are increasing their efforts to explore diverse applications of these particles in healthcare, cosmetics, and other electronic industries. The emerging players in this field are evaluating the application of nanoparticle carriers in cancer treatment. Presently, lipid nanoparticle formulations have proven to be highly bioavailable and antitumor-selective in comparison to unencapsulated drugs. This may result in decreased non-cancerous cells, enhanced drug residence time, and increased solubility of hydrophobic medications. Advanced solid and ionizable lipid nanoparticles can target tumor cells and various epithelial tissues. This increasing versatility will focus on harnessing the unique properties for various applications.
3. Green Synthesis and Sustainability
With growing emphasis on the environmentally friendly and sustainable development of therapeutic products, the metal and lipid nanoparticles manufacturing market is emphasizing a sustainable nanoparticle synthesis approach. The most prominent methods for the sustainable production of lipid nanoparticles involve the utilization of plant extracts and microorganisms as a source of lipid materials. These plant-derived lipids will serve as an eco-friendly alternative to synthetic lipid precursors. On the other hand, microorganisms such as bacteria also play an essential role in the synthesis process, providing a more sustainable approach to producing lipid nanoparticles. The widespread adoption of green synthesis methods is currently aligned with the environmentally friendly footprints for the production of nanoparticles.
4. Smart and Responsive Lipid Nanoparticles
The smart and responsive lipid nanoparticles have been designed to interact with stimuli within the body, such as pH, temperature, and enzymatic activity. Lipid nanoparticles have been combined with polymeric particles such as polycaprolactone and poly lactic-co-glycolic acid that facilitate controlled drug release by considering the reaction of stimuli within the body. The crucial feature of smart and responsive lipid nanoparticles is their ability to control drug release based on stimuli response, enabling higher precision. For instance, tumor microenvironment poses low pH compared to non-tumor cells. Based on the condition, lipid nanoparticles can facilitate the selective release of drugs inside the tumor milieu, thereby enhancing drug efficacy and reducing systemic exposure.
Conclusion
The lipid nanoparticle manufacturing market is growing at a steady pace owing to the increasing demand for drug delivery systems. Nanoparticles are currently being used in oncology, neurology, and infectious diseases. The future focus will be on advanced formulation to encapsulate drugs for target-specific delivery and exploring diverse applications. The market players are also emphasizing the integration of nanoparticles in diagnostic tools for early disease detection and monitoring. In addition, the rising prominence of metal and lipid nanoparticles in healthcare will grow in the market in the upcoming years.
For more information, please read the full report by Roots Analysis on Lipid Nanoparticles Manufacturing Market, which details this market’s unique dynamics, providing insights into the historical period (2022-2023) and forecasting trends for 2023-2035.
About Author
Simran Kaur is a senior analyst who has been working as an integral part of the Roots Analysis team since 2020. Holding a master’s and bachelor’s degree in pharmacy from a prestigious institution, she embarked on her professional journey with a strong academic foundation and an interest in the life sciences domain. Her keenness to learn more about emerging trends, regulatory dynamics, and technological advancements enables her to provide comprehensive analyses.
About Roots Analysis
Roots Analysis is a global leader in pharma and biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists, and strategic investors for more than a decade, Roots Analysis offers a highly analytical and data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by this firm are structured in a way that enables the reader to develop a thorough perspective on the given subject.
